Heart rate variability in patients with chronic heart failure and chronic obstructive pulmonary disease: clinical parallels

Cover Page


Cite item

Full Text

Abstract

Diseases comorbidity issues are of concern of many researchers, in recent decades, there are attempts to understand the hierarchy of diseases cause-and-effect relationships. Integrative approach to the patient’s condition assessment, whose comorbidity index increases with aging, is of great practical importance, since it allows the practitioner to choose the best drug therapy strategy and to objectively assess the risk of adverse cardiovascular events. Cardiovascular diseases, including those associated with bronchopulmonary system diseases, occupy leading position in mortality rate. One of the most common combinations in clinical practice is a combination of heart failure and chronic obstructive pulmonary disease. Their pathogenetic relationship may be due to common for diseases neurohumoral imbalance. The review presents data on the prevalence and mortality of patients with congestive heart failure and chronic obstructive pulmonary disease, describes the importance of autonomic nervous system dysfunction assessment in cardiovascular and bronchopulmonary diseases combination. Data on the heart rate variability assessment informativeness from the perspective of the clinical characteristics determination relevance and prognosis in patients with congestive heart failure and chronic obstructive pulmonary disease are presented. The main assessed time-domain and spectral parameters are narrated. The results of the heart rate variability parameters study in multicenter clinical trials in patients groups with heart failure and bronchopulmonary obstruction, which define the clinical and prognostic predictors among the heart rate variability parameters, are presented. In general, information on heart rate variability in congestive heart failure in comorbidity with chronic obstructive pulmonary disease is scantily presented in the available literature.

About the authors

V M Gazizianova

Kazan State Medical University

Author for correspondence.
Email: violetttakoshka2006@rambler.ru

O V Bulashova

Kazan State Medical University

Email: violetttakoshka2006@rambler.ru

E V Khazova

Kazan State Medical University

Email: violetttakoshka2006@rambler.ru

A A Nasybullina

Kazan State Medical University

Email: violetttakoshka2006@rambler.ru

M I Malkova

Kazan State Medical University

Email: violetttakoshka2006@rambler.ru

References

  1. Авдеев С.Н., Баймаканова Т.Е. ХОБЛ и сердечно-сосудистые заболевания: механизмы ассоциации. Пульмонология. 2008; (1): 5-13.
  2. Беленков Ю.Н., Мареев В.Ю., Скворцов А.А. и др. Эналаприл против карведилола. Сравнительное рандомизированное исследование у больных с хронической сердечной недостаточностью (ЭКСТАЗ). Сердечн. недост. 2001; (2): 84-91.
  3. Волчкова Е.А., Затейщикова А.А., Шаврин И.В. и др. Ассоциация параметров вариабельности ритма сердца с тяжестью бронхиальной обструкции и наличием лёгочной гипертензии у больных хронической обструктивной болезнью лёгких. Кардиология. 2012; (7): 42-48.
  4. Колодяжная О.И. Гендерные особенности вариабельности ритма сердца у пациентов с хронической сердечной недостаточностью зрелого и пожилого возраста. Врач-аспирант. 2013; 57 (2.3): 477-484.
  5. Макаров Л.М. Холтеровское мониторирование ЭКГ. М: Медпрактика-М, 2003; 340 с.
  6. Мареев В.Ю., Агеев Ф.Т., Арутюнов Г.П. и др. Национальные рекомендации ВНОК и ОССН по диагностике и лечению ХСН (IV пересмотр). Ж. сердечн. недост. 2013; (7): 379-472.
  7. Трубников Г.А., Уклистая Т.А., Андросюк Н.Г. и др. Ремоделирование сердца в свете изменений иммунного статуса у больных хронической обструктивной болезнью лёгких. Клин. мед. 2006; (4): 34-38.
  8. Чучалин А.Г., Айсанов З.Р., Авдеев С.Н. и др. Федеральные клинические рекомендации по диагностике и лечению хронической обструктивной болезни лёгких. М. 2013. www.pulmonology.ru/publications/guide.php?clear_cache=Y (дата обращения: 20.05.2015).
  9. Шугушев Х.Х., Гаева А.А. Влияние фуросемида и торасемида на вариабельность сердечного ритма и желудочковые аритмии у больных с хронической сердечной недостаточностью, осложнившей течение ишемической болезни сердца: сравнительное нерандомизированное исследование. Рационал. фармакотерап. в кардиол. 2010; 6 (4): 513-517.
  10. Aronson D., Burger A.J. Effect of beta-blockade on heart rate variability in decompensated heart failure. Int. J. Cardiol. 2001, 79: 31-39. http://dx.doi.org/10.1016/S0167-5273(01)00401-6
  11. Bédard M.E., Marquis K., Poirier P. et al. Reduced heart rate variability in patients with chronic obstructive pulmonary disease independent of anticholinergic or β-agonist medications. COPD. 2010; 7 (6): 391-397. http://dx.doi.org/10.3109/15412555.2010.528083
  12. Borghi-Silva A., Arena R., Castello V. at al. Aerobic exercise training improves autonomic nervous control in patients with COPD. Respir. Med. 2009; 103: 1503-1510. http://dx.doi.org/10.1016/j.rmed.2009.04.015
  13. Boveda M., Galinier M., Pathak A. et al. Prognostic value of heart rate variability in time domain analysis in congestive heart failure. J. Interv. Card. Electophysiol. 2001; 5 (2): 181-187. http://dx.doi.org/10.1023/A:1011485609838
  14. Buist A.S., McBurnie M.A., Vollmer W.M. et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet. 2007; 370: 741-750. http://dx.doi.org/10.1016/S0140-6736(07)61377-4
  15. Chlabra S.K., Gupta M., Ramaswamy S. et al. Cardiac sympathetic dominance and systemic inflammation in COPD. COPD. 2015; 12 (5): 552-559. http://dx.doi.org/10.3109/15412555.2014.974743
  16. Gunduz H., Talay F., Arinc H. et al. Heart rate variability and heart rate turbulence in patients with chronic obstructive pulmonary disease. Cardiol. J. 2009; 16 (5): 553-559.
  17. Haarmann H., Mohrlang C., Tschiesner U. et al. Inhaled β-agonist does not modify sympathetic activity in patients with COPD. BMC Pulm. Med. 2015; 15 (1): 46. http://dx.doi.org/10.1186/s12890-015-0054-7
  18. Hillebrand S., Gast Karin B. Heart rate variability and first cardiovascular event in populations without known cardiovascular disease: meta-analysis and dose-response meta-regression. Europace. 2013; 15: 742-749. http://dx.doi.org/10.1093/europace/eus341
  19. Kudaiberdieva G., Gorenek B., Timuralp B. Heart rate variability as a predictor of sudden cardiac death. Anatol. J. Cardiol. 2007; 7 (1): 68-70.
  20. Lasisi G.T., Adebola A.P., Ogah O.S. et al. Prevalence of ventricular arrhythmias and heart rate variability pattern in chronic heart failure. Niger Postgrad. Med. J. 2012; 19 (3): 157-162.
  21. Mosterd A., Hoes A.W. Clinical epidemiology of heart failure. Heart. 2007; 93: 1137-1146. http://dx.doi.org/10.1136/hrt.2003.025270
  22. Musialik-Lydka A., Sredniawa B., Pasyk S. Heart rate variability in heart failure. Cardiol. Pol. 2003; 58 (1): 10-16.
  23. Nolan J., Batin Phillip D., Andrews R. et al. Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom Heart failure evaluation and assessment of risk trial (UK-Heart). Circulation. 1998; 98 (15): 1510-1516. http://dx.doi.org/10.1161/01.CIR.98.15.1510
  24. Paschoal M.A., Petrelluzzi K.F.S., Gonçalves N.V.O. et al. Estudo da variabilidade da frequencia cardiac em pacientes com doenca pulmonary obstructive cronica. Rev. Cienc. Med. 2002; 11 (1): 27-37.
  25. Reis M.S., Arena R., Deus A.P. et al. Deep breathing heart-rate variability is associated with respiratory muscle weakness in patients with chronic obstructive pulmonary disease. Clinics. 2010; 65: 369-375. http://dx.doi.org/10.1590/S1807-59322010000400004
  26. Sidney S., Sorel M., Quesenberry C.P. et al. COPD and incident cardiovascular disease hospitalizations and mortality. Chest. 2005; 128: 2068-2075. http://dx.doi.org/10.1378/chest.128.4.2068
  27. Sin D.D., Wong E., Mayers I. et al. Effects of nocturnal noninvasive mechanical ventilation on heart rate variability patients with advanced COPD. Chest. 2007; 131 (1): 156-163. http://dx.doi.org/10.1378/chest.06-1423
  28. Van Gestel A.J., Kohler M., Steier J. et al. Cardiac autonomic dysfunction and health-related quality life in patients with chronic obstructive pulmonary disease. Respirology. 2011; 16: 939-946. http://dx.doi.org/10.1111/j.1440-1843.2011.01992.x
  29. Volterrani M., Scalvini S., Mazzuero G. Decreased heart rate variability in patients with chronic obstructive pulmonary disease. Chest. 1994; 106 (5): 1432-1437. http://dx.doi.org/10.1378/chest.106.5.1432
  30. Wu Y.K., Huang C.Y., Yang M.C. at al. Effect of tiotropium on heart rate variability in stable chronic obstructive pulmonary disease patients. J. Aerosol. Med. Pulm. Drug Deliv. 2015; 28 (2): 100-105. http://dx.doi.org/10.1089/jamp.2014.1125
  31. Zamarron C., Lado M.J. et al. Heart rate variability in patients with severe chronic obstructive pulmonary disease in a home care program. Technol. Health Care. 2014; 22 (1): 91-98.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

© 2016 Gazizianova V.M., Bulashova O.V., Khazova E.V., Nasybullina A.A., Malkova M.I.

Creative Commons License

This work is licensed
under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.




This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies